Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

Neuronet Working Group on data sharing holds an online meeting, identifying key challenges and obstacles

27th January 202122nd December 2020
Neuronet WG on data sharing

The Neuronet Working Groups (WGs) are cross-project spaces for experts to discuss common issues, priorities

Describing the Alzheimer’s disease data landscape: AETIONOMY researchers publish an article in Alzheimer’s & Dementia – Translational Research and Clinical Interventions

22nd December 202016th December 2020
Evaluating the Alzheimer’s disease data landscape: issues with heterogeneity, bias and interoperability

Longitudinal cohort studies are of particular value for research on progressive, neurodegenerative diseases like Alzheimer’s

RADAR-CNS Epilepsy Study 2 begins recruitment

1st April 20229th December 2020
RADAR-CNS logo

The RADAR-CNS Epilepsy Study team based at King’s College London have this week recruited their

AMYPAD project announces end of recruitment in the Diagnostic and Patient Management Study

14th December 20204th December 2020
AMYPAD logo

On 1 November, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) project

The final EPAD dataset is now available to the entire research community

19th January 202230th November 2020
3 EPAD 800x535 European Prevention of Alzheimer's Dementia Consortium

The European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the external

IMPRiND Coordinator awarded MRC Senior Clinical Fellowship

3rd March 202230th November 2020
imprind logo

Congratulations to George Tofaris, IMPRiND coordinator and member of Neuronet’s Scientific Coordination Board, who has

European Commission presents its Pharmaceutical Strategy for Europe

27th November 202027th November 2020
European Commission open access publishing platform

On 25 November, the European Commission published its Pharmaceutical Strategy for Europe, which aims to

RCSI STEM careers promotion talks present PD-MitoQUANT to young people

17th August 202226th November 2020
PD-MITOQUANT logo Newsletter Mitochondrial dysfunction Parkinson

Midlands Science partnered with Helena Bonner, a Neuroscientist at the Royal College of Surgeons in

Introducing Open Research Europe – The European Commission open access publishing platform

21st January 202224th November 2020
European Commission open access publishing platform

The European Comission is preparing the launch of Open Research Europe, the European Commission scientific

#dHealth4Trials: a new channel on the use of Digital Health in regulatory clinical trials

20th January 202223rd November 2020
Mobilise-D - Logo Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

A new discussion channel called #dHealth4Trials is now open on the In Silico World Community

Post navigation
Older posts
Newer posts
← Previous Page1 … Page15 Page16 Page17 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT